Literature DB >> 11375369

Prevalence of polycystic ovary syndrome among premenopausal women with type 2 diabetes.

H R Peppard1, J Marfori, M J Iuorno, J E Nestler.   

Abstract

OBJECTIVE: Women with polycystic ovary syndrome (PCOS) have an increased risk for developing type 2 diabetes. Few studies have assessed women with type 2 diabetes to determine the frequency of PCOS in this population. RESEARCH DESIGN AND METHODS: To determine the prevalence of PCOS among premenopausal women with type 2 diabetes, we conducted a retrospective cross-sectional prevalence study. We reviewed the medical records of all women seen in the Diabetes Clinic of the Medical College of Virginia Hospitals between January 1995 through February 2000. A diagnosis of PCOS was based on 1) oligomenorrhea, 2) hyperandrogenism (biochemical or clinical), and 3) exclusion of other related disorders.
RESULTS: We reviewed the medical records of 618 women with diabetes and identified 47 women eligible for study. Of the 47 women, 30 consented to an evaluation. Of the 30 women evaluated, 8 were identified as having PCOS (6 women reported a previous PCOS diagnosis and 2 women were newly diagnosed), resulting in a prevalence of 26.7%.
CONCLUSIONS: We concluded that PCOS occurs frequently among premenopausal women with type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11375369     DOI: 10.2337/diacare.24.6.1050

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  22 in total

1.  The clinical biochemistry of obesity.

Authors:  Ken A Sikaris
Journal:  Clin Biochem Rev       Date:  2004-08

Review 2.  Ovarian aging in women with diabetes: An overview.

Authors:  Melissa F Wellons; Juliana J Matthews; Catherine Kim
Journal:  Maturitas       Date:  2016-12-02       Impact factor: 4.342

Review 3.  The metabolic syndrome in polycystic ovary syndrome.

Authors:  P A Essah; J E Nestler
Journal:  J Endocrinol Invest       Date:  2006-03       Impact factor: 4.256

4.  Sexual function and hormonal profiles in women with and without polycystic ovary syndrome: a population-based study.

Authors:  M Noroozzadeh; F Ramezani Tehrani; S Sedigh Mobarakabadi; M Farahmand; M Rostami Dovom
Journal:  Int J Impot Res       Date:  2016-09-22       Impact factor: 2.896

Review 5.  Insulin resistance and PCOS: chicken or egg?

Authors:  P Moghetti; F Tosi
Journal:  J Endocrinol Invest       Date:  2020-07-09       Impact factor: 4.256

Review 6.  Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.

Authors:  Héctor F Escobar-Morreale
Journal:  Nat Rev Endocrinol       Date:  2018-03-23       Impact factor: 43.330

Review 7.  Metformin and gestational diabetes.

Authors:  Charles J Glueck; Naila Goldenberg; Patricia Streicher; Ping Wang
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

Review 8.  The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Authors:  Robert L Rosenfield; David A Ehrmann
Journal:  Endocr Rev       Date:  2016-07-26       Impact factor: 19.871

Review 9.  Glucose intolerance states in women with the polycystic ovary syndrome.

Authors:  R Pasquali; A Gambineri
Journal:  J Endocrinol Invest       Date:  2013-09       Impact factor: 4.256

Review 10.  [Insulin resistance in polycystic ovary syndrome].

Authors:  Annika K Schröder; Sascha Tauchert; Olaf Ortmann; Klaus Diedrich; Jürgen M Weiss
Journal:  Wien Klin Wochenschr       Date:  2003-12-15       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.